We are live on ! Find out more
KIN

Kindred Biosciences, Inc.
KIN

Delisted

KIN was delisted on the 27th of August, 2021.

Back to rankings

82 hedge funds and large institutions have $117M invested in Kindred Biosciences, Inc. in 2020 Q4 according to their latest regulatory filings, with 13 funds opening new positions, 28 increasing their positions, 19 reducing their positions, and 8 closing their positions.

New
Increased
Maintained
Reduced
Closed

63% more first-time investments, than exits

New positions opened: 13 | Existing positions closed: 8

47% more repeat investments, than reductions

Existing positions increased: 28 | Existing positions reduced: 19

6% more funds holding

Funds holding: 77 → 82 (+5)

4% more capital invested

Capital invested by funds: $113M → $117M (+$4.16M)

34% less call options, than puts

Call options by funds: $158K | Put options by funds: $239K

Holders
82
Holders Change
+5
Holders Change %
+6.49%
% of All Funds
1.45%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
13
Increased
28
Reduced
19
Closed
8
Calls
$158K
Puts
$239K
Net Calls
-$81K
Net Calls Change
-$406K

Top Buyers

Rank Fund Capital Flow
1
AI
Ariel Investments
Illinois
+$990K
2
Jacobs Levy Equity Management
Jacobs Levy Equity Management
New Jersey
+$880K
3
Acadian Asset Management
Acadian Asset Management
Massachusetts
+$690K
4
BlackRock
BlackRock
New York
+$441K
5
Wells Fargo
Wells Fargo
California
+$320K

Top Sellers

Rank Fund Capital Flow
1
GAI
General American Investors
New York
-$881K
2
GIM
Granahan Investment Management
Massachusetts
-$595K
3
GCP
GSA Capital Partners
United Kingdom
-$186K
4
Dimensional Fund Advisors
Dimensional Fund Advisors
Texas
-$153K
5
Russell Investments Group
Russell Investments Group
United Kingdom
-$153K
Name Holding Trade Value Shares
Change 		Change in
Stake
Charles Schwab
26
Charles Schwab
California
$416K – – –
Millennium Management
27
Millennium Management
New York
$349K +$50.8K +12,481 +18%
California Public Employees Retirement System
28
California Public Employees Retirement System
California
$327K -$6.51K -1,600 -2%
UBS Group
29
UBS Group
Switzerland
$325K -$35.4K -8,700 -10%
Susquehanna International Group
30
Susquehanna International Group
Pennsylvania
$319K +$44.5K +10,949 +17%
Los Angeles Capital Management
31
Los Angeles Capital Management
California
$306K -$11.9K -2,930 -4%
Cambridge Investment Research Advisors
32
Cambridge Investment Research Advisors
Iowa
$273K – – –
HighTower Advisors
33
HighTower Advisors
Illinois
$270K – – –
California State Teachers Retirement System (CalSTRS)
34
California State Teachers Retirement System (CalSTRS)
California
$249K – – –
AFM
35
Anson Funds Management
Texas
$247K +$233K +57,277 New
Citadel Advisors
36
Citadel Advisors
Florida
$224K -$105K -25,706 -33%
Deutsche Bank
37
Deutsche Bank
Germany
$211K +$28K +6,888 +16%
RhumbLine Advisers
38
RhumbLine Advisers
Massachusetts
$210K +$14.8K +3,640 +8%
AllianceBernstein
39
AllianceBernstein
Tennessee
$185K – – –
DA
40
DCF Advisers
Connecticut
$172K +$163K +40,000 New
CIM
41
CIM Investment Management
Pennsylvania
$163K – – –
PP
42
PDT Partners
New York
$147K -$20.5K -5,050 -13%
NSEDCP
43
NJ State Employees Deferred Compensation Plan
New Jersey
$138K – – –
Edgewood Management
44
Edgewood Management
Connecticut
$129K – – –
VF
45
Virtu Financial
New York
$129K +$122K +29,908 New
Two Sigma Investments
46
Two Sigma Investments
New York
$122K +$115K +28,392 New
Manulife (Manufacturers Life Insurance)
47
Manulife (Manufacturers Life Insurance)
Ontario, Canada
$115K +$5.24K +1,287 +5%
TA
48
Teton Advisors
New York
$112K – – –
PPA
49
Parametric Portfolio Associates
Washington
$112K +$2.8K +689 +3%
SIA
50
Sit Investment Associates
Minnesota
$93K – – –
1
2
3 4

KIN Hedge Fund Activity: Q4 2020 in Review

82 of the 5,651 institutional investors tracked by Wall St. Rank reported a position in Kindred Biosciences, Inc. (KIN) for Q4 2020, worth a combined $117M — up 3.7% from $113M a quarter earlier.

Buyers outnumbered sellers: 13 funds opened new KIN positions and 8 closed out — a net gain of 5 holders — while 28 added to existing stakes and 19 trimmed.

The largest buyer was Ariel Investments, adding an estimated $990K. The largest seller was General American Investors, cutting an estimated $881K.

  • 82 institutional investors held Kindred Biosciences, Inc. (KIN) as of Q4 2020, up from 77 in Q3 2020.
  • Funds reported $117M of Kindred Biosciences, Inc. stock for Q4 2020, up 3.7% quarter-over-quarter.
  • 13 funds opened new Kindred Biosciences, Inc. positions in Q4 2020 and 8 closed out, a net change of +5 holders.
  • The largest Kindred Biosciences, Inc. buyer in Q4 2020 was Ariel Investments, an estimated $990K added.
  • The largest Kindred Biosciences, Inc. seller in Q4 2020 was General American Investors, an estimated $881K sold.

Based on aggregated 13F filings for Q4 2020.